• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE; IMPLANTABLE LEAD Back to Search Results
Model Number 0157
Medical Device Problem Codes Signal Artifact/Noise (1036); Fracture (1260); High impedance (1291); Over-Sensing (1438); Pacing Problem (1439)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/15/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited noise, which was oversensed resulting in the delivery of one round of inappropriate anti-tachycardia pacing (atp) therapy.It was noted that there were no adverse effects on the patients health status as a result of the inappropriate therapy.The rv lead was surgically abandoned and replaced.No additional patient adverse effects were reported.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
It was reported that this patient heard tones from their implantable cardioverter defibrillator (icd) device.The patient was referred to their following clinic for review.It was subsequently determined that this right ventricular (rv) lead had exhibited sudden high out of range pace impedance.The rv lead also exhibited noise, which was oversensed resulting in the delivery of one round of inappropriate anti-tachycardia pacing (atp) therapy.It was noted that there were no adverse effects on the patients health status as a result of the inappropriate atp therapy, as it was not felt by the patient and did not cause any arrhythmia.The rv lead was determined to be fractured.The patients following physician initially chose to leave the icd device on with modified programming.The rv lead was subsequently surgically abandoned and replaced.No additional patient adverse effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15129286
Report Number2124215-2022-28152
Device Sequence Number6625082
Product Code LWS
UDI-Device Identifier00802526531125
UDI-Public00802526531125
Combination Product (Y/N)Y
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P910073/S039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2003
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date03/07/2005
Device Model Number0157
Device Catalogue Number0157
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/18/2022
Supplement Date Received by Manufacturer07/18/2022
Initial Report FDA Received Date07/29/2022
Supplement Report FDA Received Date08/05/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/07/2003
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age60 YR
Patient SexMale
-
-